Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 6, 2021; 9(34): 10595-10603
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10595
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10595
Table 6 Comparison of the adverse reactions between the two groups, n (%)
| Groups | n | Nausea | Emesis | Hypotension | Drowsiness | Uroschesis | Incidence of adverse reactions |
| Remimazolam group | 40 | 1 | 0 | 1 | 1 | 1 | 4 (10.00) |
| Propofol group | 40 | 3 | 1 | 3 | 3 | 2 | 12 (30.00) |
| χ2 value | 5.000 | ||||||
| P value | 0.025 |
- Citation: Tang F, Yi JM, Gong HY, Lu ZY, Chen J, Fang B, Chen C, Liu ZY. Remimazolam benzenesulfonate anesthesia effectiveness in cardiac surgery patients under general anesthesia. World J Clin Cases 2021; 9(34): 10595-10603
- URL: https://www.wjgnet.com/2307-8960/full/v9/i34/10595.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i34.10595